TITLE
Breast cancer and docetaxel treatment

SUMMARY
Breast cancer core biopsies taken from patients found to be resistant (greater than 25% residual tumor volume) or sensitive (less than 25% residual tumor volume) to docetaxel treatment.

ORGANISM
Homo sapiens

PLATFORM
GPL8300 : [HG_U95Av2] Affymetrix Human Genome U95 Version 2 Array

CITATIONS
Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG et al. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. J Clin Oncol 2005 Feb 20;23(6):1169-77. PMID:Â  15718313

